Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
41%
OVERLAP
BY WEIGHT
16
# OF OVERLAPPING
HOLDINGS
BBH
27
HOLDINGS
64%
ALSO IN FBT
FBT
31
HOLDINGS
53%
ALSO IN BBH
SECTOR DRIFT (BBH minus FBT)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
| REGENERON PHARMACEUTICALS | 7.5% | 3.9% | 3.9% | |
| GILEAD SCIENCES INC | 14.3% | 3.6% | 3.6% | |
| AMGEN INC | 16.5% | 3.6% | 3.6% | |
| VERTEX PHARMACEUTICALS INC | 8.3% | 3.5% | 3.5% | |
| ARGENX SE ADR | 4.1% | 3.4% | 3.4% | |
BBH Overweight Relative to FBT
| AMGEN INC | 13.0% | |
| GILEAD SCIENCES INC | 10.7% | |
| MODERNA, INC. | 6.6% | |
| VERTEX PHARMACEUTICALS INC | 4.8% | |
| IQVIA HOLDINGS INC | 4.2% | |
| REVOLUTION MEDICINES, INC. | 3.7% | |
| REGENERON PHARMACEUTICALS | 3.6% | |
| GUARDANT HEALTH, INC. | 2.9% | |
| INSMED INC | 2.0% | |
| CHARLES RIVER LABORATORIES | 1.7% |
BBH Underweight Relative to FBT
| GENMAB A/S SPONSORED ADR | -4.9% | |
| HALOZYME THERAPEUTICS INC | -3.8% | |
| EXELIXIS INC | -3.7% | |
| ALKERMES PLC | -3.5% | |
| VERACYTE INC | -3.5% | |
| TG THERAPEUTICS INC | -3.5% | |
| ADMA BIOLOGICS, INC. | -3.5% | |
| NEOGENOMICS INC | -3.4% | |
| TARSUS PHARMACEUTICALS, INC. | -3.3% | |
| REPLIGEN CORP | -3.2% |